OR 3.1 (95 % CI 1.5 – 6.6; p = 0.003) was calculated in our study group of affected individuals meaning the probability of having GJB2 mutations is 3.1 times higher in case of profound or severe HL (Table 9). The gene discussed is GJB2; the disease is Hodgkins lymphoma.